IPO registrations (S-1, F-1) · Registrants
BSD Medical Corp
- SEC CIK
- 320174 · filings on EDGAR ↗
- Name on the registration
- Perseon Corp
- Former names
- Perseon Corp (2015–2016)
- Registration
- Form S-1, first filed 2015-04-23, last 2015-07-28; 1 initial registration, 4 amendments
- Outcome
- Final prospectus filed 2015-07-30; declared effective 2015-07-29
- Industry (SIC)
- Electromedical & Electrotherapeutic Apparatus 3845
- Incorporated in
- DE
- Business address
- 1969 CLAREMONT DR., Bountiful, UT 84010
- EIN
- 75-1590407
- EDGAR entity type
- operating
- Insiders and CEO pay
- BSD Medical Corp on the corporate pages
Offering terms
- Final price
- $45.00 per share (424B4 filed 2015-07-30)
- Shares sold
- 5,750,000
- Gross proceeds
- $258,750,000 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol PRSN
- Lead underwriters
- Maxim Group
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Form 5500 plan sponsor: PERSEON CORPORATION EXACT (EIN (EXACT))
- SEC filer: BSD MEDICAL CORP EXACT (CIK (EXACT))
Filings 10
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2015-04-23 | S-1 | S-1 (registration) | Perseon Corp | 0001096906-15-000423 ↗ |
| 2015-05-13 | S-1/A | S-1/A (amendment) | Perseon Corp | 0001096906-15-000520 ↗ |
| 2015-07-17 | S-1/A | S-1/A (amendment) | Perseon Corp | 0001096906-15-000787 ↗ |
| 2015-07-27 | S-1/A | S-1/A (amendment) | Perseon Corp | 0001096906-15-000810 ↗ |
| 2015-07-28 | S-1/A | S-1/A (amendment) | Perseon Corp | 0001096906-15-000815 ↗ |
| 2015-07-29 | EFFECT | EFFECT (declared effective) | Perseon Corp | 9999999995-15-002094 ↗ |
| 2015-07-30 | 424B4 | 424B4 (final prospectus) | Perseon Corp | 0001096906-15-000826 ↗ |
| 2017-01-24 | EFFECT | EFFECT (declared effective) | BSD Medical Corp | 9999999995-17-000183 ↗ |
| 2017-01-24 | EFFECT | EFFECT (declared effective) | BSD Medical Corp | 9999999995-17-000184 ↗ |
| 2017-01-24 | EFFECT | EFFECT (declared effective) | BSD Medical Corp | 9999999995-17-000186 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2015-07-28 | S-1/A | registration statement | $45.00 | - | - | Nasdaq PRSN | 1 | primary document; price sentence, cover names 1 | document ↗ | |
| 2015-07-30 | 424B4 | final prospectus | $45.00 | 5,750,000 | $258,750,000 | Nasdaq PRSN | 1 | primary document; price sentence, shares headline, proceeds computed, cover names 1 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| STEWART STEVEN G | Director | 18 | 2006–2015 | ||
| BOYD DOUGLAS | Director | 17 | 2006–2014 | ||
| Turner Paul F | Director; Director,Officer | Sr VP, CTO; Sr. VP & CTO; Sr. VP, CTO; St. VP, CTO | 14 | 2006–2011 | |
| Nobel Michael | Director | 15 | 2006–2015 | ||
| Sennewald Gerhard W | Director,TenPercentOwner; TenPercentOwner | 21 | 2006–2015 | ||
| Mead Hyrum A | Director,Officer | CEO; President; President & CEO | 14 | 2006–2009 | |
| GAUGER DENNIS P | Officer | CFO; Chief Financial Officer | 7 | 2007–2011 | |
| McQuay Timothy C | Director | 14 | 2008–2015 | ||
| Wolcott Harold R | Director,Officer | President; President and CEO | 7 | 2009–2014 | |
| Dupuy Damian E | Director | 6 | 2011–2015 | ||
| Barth William S | Officer | CFO/Corporate Secretary | 3 | 2012–2014 | |
| Carnell Clint | Director,Officer | CEO | 3 | 2014–2015 | |
| Beckham Benjamin | Other | 2 | 2015 | ||
| Hoglin Jennifer R | Officer | VP of Marketing | 2 | 2015 | |
| Turnlund Todd | Officer | VP Engineering | 2 | 2015 | |
| Meltzer Brian A. | Officer | Chief Medical Officer | 3 | 2015 | |
| VITULLI PETER | Director | 3 | 2015 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Plan sponsor | PERSEON CORPORATION | UT | Form 5500 (employee benefit plans) | EIN (EXACT) |
| Patent assignee | BSD Medical Corporation | UT | Patents (USPTO) | name and state |
| SEC filer | Perseon Corp | SEC filers (EDGAR) | CIK (EXACT) | |
| Trademark owner | BSD Medical Corporation | UT | Trademarks (USPTO) | name and state |
| Form 5500 plan sponsor | PERSEON CORPORATION | EIN (EXACT) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Electromedical & Electrotherapeutic Apparatus, UT first:
- ZEVEX INTERNATIONAL INC UT
- ENDOCARE INC CA
- ARTHROCARE CORP TX
- NOVT CORP GA
- IMAGYN MEDICAL INC CA
- CARDIAC PATHWAYS CORP CA
- SABRATEK CORP IL
- ARADIGM CORP CA
- SURVIVALINK CORP MN
- Echo Therapeutics, Inc. NJ
In other datasets, the same topic (Technology) in UT:
- Form D issuer: 3DplusMe, Inc. (Form D private offerings)
- Lobbying client: 1-800 CONTACTS (Federal lobbying (LDA))
Interests: Electromedical & Electrotherapeutic Apparatus · Technology